Just how much Medicare price negotiations will negatively impact Novo Nordisk, though, depends on what the final negotiated ...
New Rule Seeks to Expand Medicare and Medicaid Coverage of Weight Loss Drugs. The Biden Administration has proposed a new ...
The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. The Trump administration will decide ...
A coalition of obesity-related patient advocacy groups is calling on the incoming Trump administration to finalize a proposal ...
Eli Lilly's popular obesity drug Zepbound can now be covered by government-backed Medicare drug plans, CNBC reported on ...
Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will ...
The Biden administration said Medicare will negotiate discounts with drug companies on 15 drugs prescribed to treat cancer, ...
Novo sells semaglutide as Ozempic and Rybelsus for diabetes and as Wegovy for obesity. In price talks, CMS will treat the ...
Diabetes and weight loss drugs Ozempic and Wegovy have been added to the list of medications selected for Medicare price ...
The U.S. government on Friday announced a list of 15 prescription medicines targeted for Medicare price negotiations for 2027 ...
Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.